Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Healthcare Formulations Limited (HFL) is a prominent pharmaceutical and biotechnology company based in Bangladesh and a key subsidiary of the Healthcare Pharmaceuticals Limited (HPL) group. The company specializes in the development and manufacture of a diverse range of high-quality products, including oncology drugs, general pharmaceuticals, biological agents, and animal health solutions. HFL's state-of-the-art oncology facility is notably certified by the European Union Good Manufacturing Practice (EU GMP), enabling the export of advanced chemotherapeutic, cytotoxic, and targeted therapies to regulated global markets. With a focus on innovation and affordability, the company is actively involved in the production of monoclonal antibodies, insulin analogs, and biosimilar technologies to address complex diseases such as cancer and diabetes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Healthcare Formulations.